• Home
  • Orals
  • Tesofensine 500 mcg (0.5 mg) – 100 Tablets
|

Tesofensine 500 mcg (0.5 mg) – 100 Tablets

Description

Biochem Tesofensine 500 mcg – 100 Oral Tablets | Triple Monoamine Reuptake Inhibitor

Biochem Tesofensine 500 mcg (0.5 mg) – 100 Tablets is a product containing tesofensine, an orally active compound studied for its effects on appetite regulation, energy intake, body weight, and central nervous system monoamine signaling.

Tesofensine belongs to the class of triple monoamine reuptake inhibitors, meaning it inhibits the reuptake of serotonin, norepinephrine, and dopamine.

Originally investigated for neurological conditions including Parkinson's disease and Alzheimer's disease, tesofensine subsequently attracted interest in obesity research after reductions in body weight were observed during clinical investigations.

Unlike GLP-1 receptor agonists, tesofensine acts primarily through central nervous system neurotransmitter transporters rather than incretin hormone receptors.

The Biochem product is described as containing 500 mcg (0.5 mg) per tablet, with 100 tablets per package. The stated strength is not a dosage recommendation. Product identity, purity, excipients, and manufacturing specifications have not been independently verified.

SpecificationDetails
Product NameBiochem Tesofensine
Active IngredientTesofensine
Alternative NameNS2330
Labeled Strength500 mcg per tablet
Equivalent Strength0.5 mg per tablet
Package Quantity100 Tablets
Total Labeled Active Ingredient50 mg per package
Dosage FormOral Tablets
Compound ClassificationTriple Monoamine Reuptake Inhibitor
Pharmacological CategoryCentrally Acting Monoamine Transporter Inhibitor
Molecular FormulaC₁₇H₂₃Cl₂NO
Molecular WeightApproximately 328.28 g/mol (Free Base)
Commonly Studied Salt FormTesofensine Citrate
Primary Molecular TargetsSERT, NET, DAT
Serotonin Transporter ActivityReuptake Inhibition
Norepinephrine Transporter ActivityReuptake Inhibition
Dopamine Transporter ActivityReuptake Inhibition
Primary Signaling SystemCentral Monoaminergic Neurotransmission
Main Investigated ApplicationObesity and Weight Management
Historical Research AreasParkinson's Disease and Alzheimer's Disease
Approximate Terminal Half-LifeAbout 9 Days in Reported Human Studies
Administration Route StudiedOral
Regulatory StatusJurisdiction-Dependent; Not Generally Approved for Obesity Treatment
ExcipientsNot Confirmed
Manufacturing SpecificationsNot Independently Verified

1. Inhibits Serotonin Reuptake

Tesofensine inhibits the serotonin transporter (SERT), increasing serotonin availability within certain neuronal signaling pathways. Serotonin participates in appetite regulation, mood, and other central nervous system functions.

2. Inhibits Norepinephrine Reuptake

Tesofensine inhibits the norepinephrine transporter (NET), influencing neurotransmission associated with alertness, autonomic activity, and cardiovascular regulation.

This mechanism is relevant to possible increases in heart rate and blood pressure.

3. Inhibits Dopamine Reuptake

Tesofensine inhibits the dopamine transporter (DAT), affecting signaling involved in motivation, reward processing, and food-related behavior.

4. Has Demonstrated Effects on Body Weight in Clinical Studies

Controlled clinical investigations have reported reductions in body weight among selected participants receiving tesofensine.

These findings do not establish that the Biochem product has demonstrated equivalent effects or that long-term treatment is safe.

5. Influences Appetite and Food Intake

Tesofensine has been investigated for its potential to reduce appetite and influence food consumption through central monoaminergic pathways.

Its mechanism differs from medications that act through gastrointestinal hormone receptors.

6. Has a Relatively Long Elimination Half-Life

Published human studies have reported a terminal elimination half-life of approximately nine days.

This prolonged elimination period may contribute to accumulation during repeated exposure and may extend the duration of adverse effects or drug interactions.

7. Influences Cardiovascular and Central Nervous System Regulation

Tesofensine can influence heart rate, blood pressure, sleep, mood, and other neurological functions.

Reported adverse effects include dry mouth, insomnia, constipation, and cardiovascular changes. Interactions with antidepressants, stimulants, and other centrally acting drugs are important safety considerations.

Tesofensine has not been established as a generally approved obesity medication. Its long-term cardiovascular, psychiatric, reproductive, and neurological safety remains incompletely characterized. Combining it with serotonergic medications may increase the risk of serotonin toxicity.

Step 1 – Oral Administration and Gastrointestinal Absorption

Tesofensine has been administered orally in clinical studies. Following administration, it is absorbed and enters systemic circulation.

Step 2 – Distribution to the Central Nervous System

The compound reaches central nervous system tissues containing transporters involved in serotonin, norepinephrine, and dopamine signaling.

Step 3 – Inhibition of Monoamine Transporters

Tesofensine inhibits SERT, NET, and DAT, reducing neurotransmitter reuptake and altering extracellular monoamine availability.

Step 4 – Modulation of Appetite-Related Neural Pathways

Changes in monoaminergic signaling can influence appetite, food reward, and energy intake. These effects have been investigated in clinical obesity studies.

Step 5 – Metabolism and Elimination

Tesofensine undergoes metabolic processing, including formation of active metabolites. Its reported long terminal elimination half-life is relevant to potential accumulation and prolonged adverse reactions.

The Biochem Tesofensine tablet presentation is described by the following characteristics:

  • Tesofensine as the labeled active ingredient.
  • 500 mcg per tablet.
  • Equivalent to 0.5 mg per tablet.
  • 100 tablets per package.
  • 50 mg total labeled tesofensine content.
  • Oral solid-dose presentation.
  • Triple monoamine reuptake inhibition.
  • Serotonin transporter inhibition.
  • Norepinephrine transporter inhibition.
  • Dopamine transporter inhibition.
  • Central nervous system pharmacological activity.
  • Investigated effects on appetite and body weight.
  • Relatively long reported elimination half-life.
  • Potential cardiovascular and neurological adverse effects.
  • Product identity, purity, and content uniformity requiring analytical verification.

The precise tablet formulation, salt form, excipient composition, and manufacturing specifications of Biochem Tesofensine 500 mcg have not been confirmed. The 100-tablet package quantity does not establish a treatment duration.


United States

Biochem Tesofensine 500mcg, Tesofensine 0.5mg, Tesofensine 100 tablets, Tesofensine 500mcg 100 tablets, Tesofensine United States, Tesofensine oral tablets, Tesofensine pharmacology, Tesofensine mechanism of action, Tesofensine triple monoamine reuptake inhibitor, Tesofensine serotonin transporter, Tesofensine norepinephrine transporter, Tesofensine dopamine transporter, Tesofensine obesity clinical trials, Tesofensine appetite regulation, Tesofensine half life, Tesofensine cardiovascular effects, Tesofensine safety information, Tesofensine tablet specifications.

Canada

English: Biochem Tesofensine 500mcg Canada, Tesofensine 0.5mg Canada, Tesofensine 100 tablets Canada, Tesofensine oral tablets, Tesofensine pharmacology, Tesofensine mechanism of action, Tesofensine triple reuptake inhibitor, Tesofensine serotonin, Tesofensine norepinephrine, Tesofensine dopamine, Tesofensine appetite regulation, Tesofensine obesity clinical studies, Tesofensine safety information.

French: Biochem Tésofensine 500 mcg Canada, tésofensine 0,5 mg, tésofensine 100 comprimés, pharmacologie de la tésofensine, mécanisme d'action, inhibiteur de la recapture des monoamines, transporteur de la sérotonine, transporteur de la noradrénaline, transporteur de la dopamine, régulation de l'appétit, études cliniques sur l'obésité, demi-vie de la tésofensine, informations de sécurité.

United Kingdom

Biochem Tesofensine 500mcg UK, Tesofensine 0.5mg UK, Tesofensine 100 tablets UK, Tesofensine oral tablets, Tesofensine clinical research, Tesofensine pharmacology, Tesofensine mechanism of action, Tesofensine triple monoamine reuptake inhibitor, Tesofensine serotonin transporter, Tesofensine norepinephrine transporter, Tesofensine dopamine transporter, Tesofensine appetite regulation, Tesofensine obesity trials, Tesofensine half life, Tesofensine cardiovascular safety.

Germany

Biochem Tesofensin 500 mcg Deutschland, Tesofensin 0,5 mg, Tesofensin 100 Tabletten, Tesofensin Pharmakologie, Tesofensin Wirkungsmechanismus, dreifacher Monoamin-Wiederaufnahmehemmer, Serotonintransporter, Noradrenalintransporter, Dopamintransporter, Appetitregulation, Adipositas klinische Studien, Tesofensin Molekülstruktur, Tesofensin Halbwertszeit, kardiovaskuläre Wirkungen, Tesofensin Sicherheitsinformationen.

France

Biochem Tésofensine 500 mcg France, tésofensine 0,5 mg, tésofensine 100 comprimés, pharmacologie de la tésofensine, mécanisme d'action, inhibiteur de la recapture des monoamines, transporteur de la sérotonine, transporteur de la noradrénaline, transporteur de la dopamine, régulation de l'appétit, études cliniques sur l'obésité, structure moléculaire, métabolisme de la tésofensine, demi-vie de la tésofensine, informations de sécurité.

Spain

Biochem Tesofensina 500 mcg España, tesofensina 0,5 mg, tesofensina 100 tabletas, farmacología de la tesofensina, mecanismo de acción, inhibidor triple de la recaptación de monoaminas, transportador de serotonina, transportador de noradrenalina, transportador de dopamina, regulación del apetito, estudios clínicos sobre obesidad, estructura molecular, metabolismo de la tesofensina, vida media de la tesofensina, información de seguridad.

Italy

Biochem Tesofensina 500 mcg Italia, tesofensina 0,5 mg, tesofensina 100 compresse, farmacologia della tesofensina, meccanismo d'azione, inibitore della ricaptazione delle monoamine, trasportatore della serotonina, trasportatore della noradrenalina, trasportatore della dopamina, regolazione dell'appetito, studi clinici sull'obesità, struttura molecolare, metabolismo della tesofensina, emivita della tesofensina, informazioni di sicurezza.

Portugal

Biochem Tesofensina 500 mcg Portugal, tesofensina 0,5 mg, tesofensina 100 comprimidos, farmacologia da tesofensina, mecanismo de ação, inibidor triplo da recaptação de monoaminas, transportador de serotonina, transportador de noradrenalina, transportador de dopamina, regulação do apetite, estudos clínicos sobre obesidade, estrutura molecular, metabolismo da tesofensina, meia-vida da tesofensina, informações de segurança.

Netherlands

Biochem Tesofensine 500 mcg Nederland, tesofensine 0,5 mg, tesofensine 100 tabletten, farmacologie van tesofensine, werkingsmechanisme tesofensine, drievoudige monoamineheropnameremmer, serotoninetransporter, noradrenalinetransporter, dopaminetransporter, eetlustregulatie, klinische onderzoeken naar obesitas, moleculaire structuur, metabolisme van tesofensine, halfwaardetijd tesofensine, veiligheidsinformatie.

Belgium

Biochem Tesofensine 500 mcg Belgium, tésofensine 500 mcg Belgique, tesofensine 100 tabletten, tésofensine 100 comprimés, farmacologie van tesofensine, pharmacologie de la tésofensine, monoamineheropnameremmer, inhibiteur de la recapture des monoamines, serotoninetransporter, transporteur de la sérotonine, noradrenalinetransporter, transporteur de la noradrénaline, dopaminetransporter, transporteur de la dopamine, eetlustregulatie, régulation de l'appétit.

Switzerland

Biochem Tesofensine 500 mcg Switzerland, Tesofensin 500 mcg Schweiz, tésofensine 500 mcg Suisse, Tesofensin 100 Tabletten, tésofensine 100 comprimés, pharmacologie de la tésofensine, Tesofensin Wirkungsmechanismus, Monoamin-Wiederaufnahmehemmer, inhibiteur de la recapture des monoamines, Serotonintransporter, transporteur de la sérotonine, Noradrenalintransporter, transporteur de la noradrénaline, Dopamintransporter, transporteur de la dopamine, Adipositas klinische Studien.

Austria

Biochem Tesofensin 500 mcg Österreich, Tesofensin 0,5 mg, Tesofensin 100 Tabletten, Tesofensin Pharmakologie, Tesofensin Wirkungsmechanismus, Monoamin-Wiederaufnahmehemmer, Serotonintransporter, Noradrenalintransporter, Dopamintransporter, Appetitregulation, Adipositas Forschung, klinische Studien, Molekülstruktur, Tesofensin Halbwertszeit, Sicherheitsinformationen.

Sweden

Biochem Tesofensin 500 mcg Sverige, tesofensin 0,5 mg, tesofensin 100 tabletter, tesofensin farmakologi, tesofensin verkningsmekanism, trippel monoaminåterupptagshämmare, serotonintransportör, noradrenalintransportör, dopamintransportör, aptitreglering, kliniska studier om fetma, molekylstruktur, tesofensin metabolism, tesofensin halveringstid, säkerhetsinformation.

Norway

Biochem Tesofensin 500 mcg Norge, tesofensin 0,5 mg, tesofensin 100 tabletter, tesofensin farmakologi, tesofensin virkningsmekanisme, trippel monoaminreopptakshemmer, serotonintransportør, noradrenalintransportør, dopamintransportør, appetittregulering, kliniske studier om fedme, molekylstruktur, tesofensin metabolisme, tesofensin halveringstid, sikkerhetsinformasjon.

Denmark

Biochem Tesofensin 500 mcg Danmark, tesofensin 0,5 mg, tesofensin 100 tabletter, tesofensin farmakologi, tesofensin virkningsmekanisme, tredobbelt monoamingenoptagelseshæmmer, serotonintransportør, noradrenalintransportør, dopamintransportør, appetitregulering, kliniske studier om fedme, molekylstruktur, tesofensin metabolisme, tesofensin halveringstid, sikkerhedsinformation.

Finland

Biochem Tesofensiini 500 mcg Suomi, tesofensiini 0,5 mg, tesofensiini 100 tablettia, tesofensiinin farmakologia, tesofensiinin vaikutusmekanismi, monoamiinien takaisinoton estäjä, serotoniinin kuljettajaproteiini, noradrenaliinin kuljettajaproteiini, dopamiinin kuljettajaproteiini, ruokahalun säätely, lihavuuden kliiniset tutkimukset, molekyylirakenne, tesofensiinin puoliintumisaika, turvallisuustiedot.

Poland

Biochem Tesofensyna 500 mcg Polska, tesofensyna 0,5 mg, tesofensyna 100 tabletek, farmakologia tesofensyny, mechanizm działania tesofensyny, inhibitor wychwytu zwrotnego monoamin, transporter serotoniny, transporter noradrenaliny, transporter dopaminy, regulacja apetytu, badania kliniczne nad otyłością, struktura molekularna, metabolizm tesofensyny, okres półtrwania tesofensyny, informacje o bezpieczeństwie.

Czech Republic

Biochem Tesofensin 500 mcg Česko, tesofensin 0,5 mg, tesofensin 100 tablet, farmakologie tesofensinu, mechanismus účinku tesofensinu, inhibitor zpětného vychytávání monoaminů, serotoninový transportér, noradrenalinový transportér, dopaminový transportér, regulace chuti k jídlu, klinické studie obezity, molekulární struktura, metabolismus tesofensinu, poločas tesofensinu, bezpečnostní informace.

Romania

Biochem Tesofensină 500 mcg România, tesofensină 0,5 mg, tesofensină 100 comprimate, farmacologia tesofensinei, mecanism de acțiune tesofensină, inhibitor al recaptării monoaminelor, transportorul serotoninei, transportorul noradrenalinei, transportorul dopaminei, reglarea apetitului, studii clinice privind obezitatea, structură moleculară, metabolismul tesofensinei, timpul de înjumătățire, informații de siguranță.

Greece

Biochem Tesofensine 500 mcg Ελλάδα, τεσοφενσίνη 0,5 mg, τεσοφενσίνη 100 δισκία, φαρμακολογία τεσοφενσίνης, μηχανισμός δράσης τεσοφενσίνης, αναστολέας επαναπρόσληψης μονοαμινών, μεταφορέας σεροτονίνης, μεταφορέας νοραδρεναλίνης, μεταφορέας ντοπαμίνης, ρύθμιση της όρεξης, κλινικές μελέτες παχυσαρκίας, μοριακή δομή, μεταβολισμός τεσοφενσίνης, χρόνος ημιζωής, πληροφορίες ασφάλειας.

Ireland

Biochem Tesofensine 500mcg Ireland, Tesofensine 0.5mg Ireland, Tesofensine 100 tablets Ireland, Tesofensine pharmacology, Tesofensine mechanism of action, Tesofensine triple monoamine reuptake inhibitor, Tesofensine serotonin transporter, Tesofensine norepinephrine transporter, Tesofensine dopamine transporter, Tesofensine appetite regulation, Tesofensine obesity clinical studies, Tesofensine molecular composition, Tesofensine elimination half life, Tesofensine safety information.


Colombia

Biochem Tesofensina 500 mcg Colombia, tesofensina 0,5 mg Colombia, tesofensina 100 tabletas, farmacología de la tesofensina, qué es la tesofensina, cómo funciona la tesofensina, mecanismo de acción de la tesofensina, inhibidor triple de la recaptación de monoaminas, transportador de serotonina, transportador de noradrenalina, transportador de dopamina, regulación del apetito, estudios clínicos de obesidad, estructura molecular, metabolismo de la tesofensina, vida media de la tesofensina, información de seguridad.

Argentina

Biochem Tesofensina 500 mcg Argentina, tesofensina 0,5 mg Argentina, tesofensina 100 comprimidos, farmacología de la tesofensina, qué es la tesofensina, cómo actúa la tesofensina, mecanismo de acción de la tesofensina, inhibidor de la recaptación de monoaminas, transportador de serotonina, transportador de noradrenalina, transportador de dopamina, regulación del apetito, investigación clínica sobre obesidad, estructura molecular, metabolismo de la tesofensina, vida media de la tesofensina, información de seguridad.

México

Biochem Tesofensina 500 mcg México, tesofensina 0,5 mg México, tesofensina 100 tabletas, farmacología de la tesofensina, para qué se estudia la tesofensina, cómo funciona la tesofensina, mecanismo de acción de la tesofensina, inhibidor triple de la recaptación de monoaminas, transportador de serotonina, transportador de noradrenalina, transportador de dopamina, regulación del apetito, estudios clínicos sobre obesidad, estructura molecular, metabolismo de la tesofensina, vida media de la tesofensina, información de seguridad.

Perú

Biochem Tesofensina 500 mcg Perú, tesofensina 0,5 mg Perú, tesofensina 100 tabletas, farmacología de la tesofensina, qué es la tesofensina, cómo funciona la tesofensina, mecanismo de acción de la tesofensina, inhibidor de la recaptación de monoaminas, transportador de serotonina, transportador de noradrenalina, transportador de dopamina, regulación del apetito, estudios clínicos de obesidad, estructura molecular, metabolismo de la tesofensina, vida media de la tesofensina, información de seguridad.

Venezuela

Biochem Tesofensina 500 mcg Venezuela, tesofensina 0,5 mg Venezuela, tesofensina 100 tabletas, farmacología de la tesofensina, qué es la tesofensina, cómo actúa la tesofensina, mecanismo de acción de la tesofensina, inhibidor triple de la recaptación de monoaminas, transportador de serotonina, transportador de noradrenalina, transportador de dopamina, regulación del apetito, estudios clínicos sobre obesidad, estructura molecular, metabolismo de la tesofensina, vida media de la tesofensina, información de seguridad.

Ecuador

Biochem Tesofensina 500 mcg Ecuador, tesofensina 0,5 mg Ecuador, tesofensina 100 tabletas, farmacología de la tesofensina, para qué se investiga la tesofensina, cómo funciona la tesofensina, mecanismo de acción de la tesofensina, inhibidor triple de la recaptación de monoaminas, transportador de serotonina, transportador de noradrenalina, transportador de dopamina, regulación del apetito, estudios clínicos de obesidad, estructura molecular, metabolismo de la tesofensina, vida media de la tesofensina, información de seguridad.


Biochem Tesofensine 500mcg | 100 Tablets | Triple Monoamine Reuptake Inhibitor

Learn about Biochem Tesofensine 500mcg (0.5mg), 100 oral tablets, a compound studied for appetite regulation and obesity through serotonin, norepinephrine, and dopamine reuptake inhibition, including pharmacology and safety considerations.

Biochem Tesofensina 500mcg | 100 Tabletas | Inhibidor Triple de Recaptación de Monoaminas

Conoce Biochem Tesofensina 500mcg (0,5mg), presentación de 100 tabletas orales, un compuesto estudiado para la regulación del apetito y la obesidad mediante la inhibición de la recaptación de serotonina, noradrenalina y dopamina.

biochem-tesofensine-500mcg-100-tablets

biochem-tesofensina-500mcg-100-tabletas

Biochem Tesofensine 500mcg (0.5mg) 100 oral tablets, a product labeled as containing tesofensine, a centrally acting triple monoamine reuptake inhibitor investigated for appetite regulation and obesity.

Biochem Tesofensina 500mcg (0,5mg) 100 tabletas orales, producto etiquetado como tesofensina, un inhibidor triple de la recaptación de monoaminas estudiado para la regulación del apetito y la obesidad.